Scientists at deCODE genetics, a subsidiary of Amgen,�reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. Significant progress has ...

The generic drug manufacturer was linked to the death of eight people last year, and was responsible for an outsized share of recalls for pills that didn’t dissolve properly and could harm people.

With the launch of the Global Partner Program, Aisera is poised to drive a new era of digital transformation, enabling partners to deliver industry-leading Agentic AI that shapes the future of ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Duska noted that the PD-L1 inhibitor pembrolizumab has shown efficacy in the treatment of recurrent or metastatic cervical ...

Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as "Dr. Reddy's") and Alvotech (NASDAQ: ALVO), a global biotech ...

Additionally, Amgen has declared a quarterly dividend of $2.38 per share for the second quarter of 2025, reflecting its ongoing commitment to shareholder returns. The company has also launched a new ...

The company has also launched a new technology and innovation site in Hyderabad, India, named Amgen India, with a $200 million investment plan through 2025. This site aims to enhance Amgen’s ...